Table 1.
Compounds | MDR Cancer Model | Inhibitors of P-gp Function | Inhibitors of P-gp Expression | References |
---|---|---|---|---|
Unsymmetrical curcumin mimics with various amide moieties | MDR cervical adenocarcinoma | X | [56] | |
Heterocyclic cyclohexanone monocarbonyl analogs of curcumin | Human embryonic kidney cells and canine kidney cells transfected with wild-type P-gp | X | [57] | |
Chloro and asymmetrical series of synthetic curcumin derivatives | MDR acute lymphoblastic leukemia | X | [58] | |
Diketone and cyclohexanone curcumin analogs | MDR chronic myeloid leukemia | X | X | [59] |
MDR: multidrug resistant.